Evidence map›Paper›PMID 25242350›Full record

ReviewHead & neck2016

Update on primary head and neck mucosal melanoma.

Fernando López, Juan P Rodrigo, Antonio Cardesa, Asterios Triantafyllou, Kenneth O Devaney, William M Mendenhall, Missak Haigentz, Primož Strojan, Phillip K Pellitteri, Carol R Bradford and 6 more

Open access · greenAbstract readReview
In one paragraph

Review in Head & neck, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 205 citations in OpenAlex.

  1. Metastatic melanoma of the major salivary glands - a systematic review.Medicina oral, patologia oral y cirugia bucal · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Sinonasal Mucosal Melanoma: A Comprehensive Review and Clinical Experience.Journal of rhinology : official journal of the Korean Rhinologic Society · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 15 institutions in 6 countries.

Fernando LópezDepartment of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Juan P RodrigoDepartment of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Antonio CardesaDepartment of Anatomic Pathology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Asterios TriantafyllouDepartment of Oral Pathology, School of Dentistry, University of Liverpool, Liverpool, United Kingdom.
Kenneth O DevaneyDepartment of Pathology, Allegiance Health, Jackson, Michigan.
William M MendenhallDepartment of Radiation Oncology, University of Florida, Gainesville, Florida.
Missak HaigentzDepartment of Medicine, Division of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
Primož StrojanDepartment of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia.
Phillip K PellitteriDepartment of Otolaryngology-Head and Neck Surgery, Guthrie Health System, Sayre, Pennsylvania.
Carol R BradfordDepartment of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Ashok R ShahaHead and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
Jennifer L HuntDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Remco de BreeDepartment of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands.
Robert P TakesDepartment of Otolaryngology-Head and Neck Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Alessandra RinaldoUniversity of Udine School of Medicine, Udine, Italy.
Alfio FerlitoUniversity of Udine School of Medicine, Udine, Italy.
University of Udine · ITAmsterdam UMC Location Vrije Universiteit Amsterdam · NLGuthrie Foundation · USHenry Ford Allegiance Health · USHospital Universitario Central de Asturias · ESInstitute of Oncology Ljubljana · SIInstituto de Investigación Sanitaria del Principado de Asturias · ESMemorial Sloan Kettering Cancer Center · USMontefiore Medical Center · USRadboud University Medical Center · NLUniversitat de Barcelona · ESUniversity of Arkansas for Medical Sciences · USUniversity of Florida · USUniversity of Liverpool · GBUniversity of Michigan · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Primary mucosal melanomas (PMMs) of the head and neck are uncommon malignancies that arise mainly in the nasal cavity and paranasal sinuses, followed by the oral cavity. The mainstay of treatment is radical surgical resection followed by adjuvant radiotherapy in selected patients with high-risk features. Multimodality therapy has not been well studied and is not standardized. Adjuvant radiotherapy seems to improve locoregional control but does not improve overall survival (OS). Elective neck dissection is advocated in patients with oral PMM. Systemic therapy should be considered only for patients with metastatic or unresectable locoregional disease. Despite improvements in the field of surgery, radiotherapy, and systemic therapy, patients with PMM still face a very unfavorable prognosis (5-year disease-free survival [DFS] <20%) with high rates of locoregional recurrence and distant metastasis. The present review aims to summarize the current state of knowledge on the molecular biology, pathological diagnosis, and management of this disease.

Indexed as

Combined Modality TherapyHead and Neck NeoplasmsHumansMelanomaMouth NeoplasmsNeoplasm Recurrence, LocalNeoplasm StagingNose NeoplasmsParanasal Sinus NeoplasmsPrognosisRisk FactorsTreatment Outcomechemotherapydiagnosishead and neckmucosal melanomaoutcomesradiotherapystaging systemsurgery

Identifiers

PMID25242350
PMCPMC4986507
OpenAlexW1908245140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.